The chemical class of 20S Proteasome β7 inhibitors encompasses a range of compounds primarily designed to target proteolytic activities within the proteasome complex. The proteasome is responsible for degrading ubiquitinated proteins and regulating protein turnover. Inhibition of the proteasome's function can affect various cellular processes, including the cell cycle, apoptosis, and the stress response. The β7 subunit is part of the 20S core particle, which has three peptidase activities: caspase-like (β1), trypsin-like (β2), and chymotrypsin-like (β5). While many inhibitors specifically target the chymotrypsin-like activity, there is cross-reactivity, and β7 activity can also be inhibited, either directly or indirectly.
The chemical class of 20S Proteasome β7 inhibitors includes a diverse group of compounds that interact with the proteasome complex, a pivotal player in cellular homeostasis through the degradation of ubiquitinated proteins. This degradation is critical for several cellular processes such as cell cycle regulation, signal transduction, and stress responses. Compounds in this class are characterized by their ability to impair the proteasome's function, thus influencing protein turnover and the fate of proteins destined for degradation. The β7 subunit is part of the 20S core of the proteasome, a multi-catalytic proteinase complex, and is involved in the peptidase activities of the proteasome.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Reversibly inhibits the 20S proteasome's chymotrypsin-like activity, affecting β5 but also impacts β1 and β7. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Irreversibly binds to and inhibits the chymotrypsin-like site of the 20S proteasome, including β7 subunit. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
A boronate peptide that selectively and reversibly inhibits the β5 subunit of the 20S proteasome and may impact β7. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
An epoxyketone-based proteasome inhibitor, targeting the β5 subunit with potential impact on β7. | ||||||
Caspofungin acetate | 179463-17-3 | sc-362016 sc-362016A | 1 mg 25 mg | $286.00 $5100.00 | ||
A beta-lactone peptide that irreversibly binds to and inhibits all three proteolytic activities of the proteasome, including β7. | ||||||
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $204.00 | 1 | |
A boronic acid derivative that inhibits the chymotrypsin-like activity of the proteasome, including β7. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A peptide aldehyde that reversibly inhibits the chymotrypsin-like and peptidylglutamyl-peptide hydrolyzing activity of the proteasome, affecting β7. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Specifically inhibits the proteasome by covalently modifying its catalytic threonine residues, including those in β7. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A naturally occurring epoxyketone that irreversibly inhibits the proteasome, including the β7 subunit. | ||||||
ONX 0914 | 960374-59-8 | sc-477437 | 5 mg | $245.00 | ||
Selectively inhibits the immunoproteasome subunit LMP7, which is analogous to the constitutive β7, potentially affecting similar pathways. | ||||||